How is the Compass Therapeutics Inc today?

The Compass Therapeutics Inc today is trading in the green, up by 2.34% at 2.62.

How has Compass Therapeutics Inc performed historically?

The Compass Therapeutics Inc is currently trading up 2.34% on an intraday basis in the past week the index rose 9.17%. The index has been up 31.66% in the past quarter and rose 162.00% in the past year. You can view this in the overview section.

What is Compass Therapeutics Inc Annual Net Profit?

Compass Therapeutics Inc Annual Net Profit fell 16.19% in the last year to $49.38 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Compass Therapeutics Inc Price to Earning Ratio?

Compass Therapeutics Inc Price to Earning Ratio is -6.56, which is negative.

What is Compass Therapeutics Inc Stock Price?

Compass Therapeutics Inc Stock Price rose 162% and outperformed its sector by 128.18% in the past year.

What is Compass Therapeutics Inc Quarterly Net profit?

Compass Therapeutics Inc Quarterly Net profit fell 54.19% YoY to $16.63 M. Its sector's average net profit growth YoY for the quarter was -235.94%.

What is Compass Therapeutics Inc Debt to Equity Ratio?

Compass Therapeutics Inc Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Compass Therapeutics Inc Return on Equity(ROE)?

Compass Therapeutics Inc Return on Equity(ROE) for the last financial year was -36.07%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Compass Therapeutics Inc Mutual Fund Holding?

Compass Therapeutics Inc Mutual Fund Holding increased by 0.28% in the last quarter to 19.32.

What is Compass Therapeutics Inc Institutional Holding?

Compass Therapeutics Inc Institutional Holding increased by 5.59% in the last quarter to 80.85.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
COMPASS THERAPEUTICS INC

Compass Therapeutics Inc XNAS: CMPX

Compass Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Compass Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Compass Therapeutics Inc
Rating: 1.97733325
Author: Trendlyne DVM scores

about

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its...

2.62 0.06 (2.34%)

35.78% Fall from 52W High

184.3K

XNAS Volume

XNAS 30 Jun, 2025 12:48 PM (EDT)

Not Eligible

Expensive Valuation

6.8 / 100

Technically Bullish

72.3 / 100

1Yr Price target upside is 405%

9 analysts

Compass Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Compass Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its...

35.78% Fall from 52W High

SWOT Analysis

Compass Therapeutics Inc Live Price Chart

Compass Therapeutics Inc FAQ

How is Compass Therapeutics Inc today?

Compass Therapeutics Inc today is trading in the green, and is up by 2.34% at 2.62.

How has Compass Therapeutics Inc performed historically?

Compass Therapeutics Inc is currently trading up 2.34% on an intraday basis. In the past week the stock rose 9.17%. stock has been up 31.66% in the past quarter and rose 162.00% in the past year. You can view this in the overview section.